Treatment strategies

Phase III study of GM-CSF in advanced HIV disease

15 June 2000. Related: Treatment strategies.

GM-CSF beneficial for patients with advanced HIV disease

15 May 2000. Related: Treatment strategies.

French National Drug Agency re-commends use of IL-2 if HAART does not lead to an increase in CD4 count to greater than 200 cells/mm3

14 April 2000. Related: Treatment strategies.